These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31443750)

  • 21. [Metabolism of heme and hemoproteins in rat liver upon administration of mercuric chloride].
    Kaliman PA; Nikitchenko IV; Barannik TV; Sokol OA
    Ukr Biokhim Zh (1999); 1999; 71(6):81-5. PubMed ID: 10820853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PGC-1alpha: looking behind the sweet treat for porphyria.
    Li D
    Cell; 2005 Aug; 122(4):487-9. PubMed ID: 16122414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
    Kim M; Tomek P
    Front Immunol; 2021; 12():636081. PubMed ID: 33708223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan pyrrolase in haem regulation. The mechanism of the opposite effects of tryptophan on rat liver 5-aminolaevulinate synthase activity and the haem saturation of tryptophan pyrrolase.
    Badawy AA; Welch AN; Morgan CJ
    Biochem J; 1981 Aug; 198(2):309-14. PubMed ID: 7326008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments.
    Manceau H; Gouya L; Puy H
    Curr Opin Hematol; 2017 May; 24(3):198-207. PubMed ID: 28118224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice.
    Oliveri LM; Davio C; Batlle AM; Gerez EN
    Biochem J; 2012 Mar; 442(2):303-10. PubMed ID: 22070747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
    Bonkovsky HL; Dixon N; Rudnick S
    Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of heme metabolism in rat hepatocytes and hepatocyte cell lines: delta-aminolevulinic acid synthase and heme oxygenase are regulated by different heme-dependent mechanisms.
    Cable EE; Miller TG; Isom HC
    Arch Biochem Biophys; 2000 Dec; 384(2):280-95. PubMed ID: 11368315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
    Tian Q; Li T; Hou W; Zheng J; Schrum LW; Bonkovsky HL
    J Biol Chem; 2011 Jul; 286(30):26424-30. PubMed ID: 21659532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.
    Yasuda M; Gan L; Chen B; Kadirvel S; Yu C; Phillips JD; New MI; Liebow A; Fitzgerald K; Querbes W; Desnick RJ
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7777-82. PubMed ID: 24821812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminolevulinate synthase catalysis: The catcher in heme biosynthesis.
    Stojanovski BM; Hunter GA; Na I; Uversky VN; Jiang RHY; Ferreira GC
    Mol Genet Metab; 2019 Nov; 128(3):178-189. PubMed ID: 31345668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria?
    Litman DA; Correia MA
    Science; 1983 Dec; 222(4627):1031-3. PubMed ID: 6648517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA interference therapy in acute hepatic porphyrias.
    Yasuda M; Keel S; Balwani M
    Blood; 2023 Nov; 142(19):1589-1599. PubMed ID: 37027823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting TDO in cancer immunotherapy.
    Yu CP; Song YL; Zhu ZM; Huang B; Xiao YQ; Luo DY
    Med Oncol; 2017 May; 34(5):73. PubMed ID: 28357780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
    May BK; Bhasker CR; Bawden MJ; Cox TC
    Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
    Schramme F; Crosignani S; Frederix K; Hoffmann D; Pilotte L; Stroobant V; Preillon J; Driessens G; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):32-45. PubMed ID: 31806638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum to "Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias" [Med. Hypotheses 131 (2019) 109314].
    Badawy AA
    Med Hypotheses; 2019 Nov; 132():109352. PubMed ID: 31470238
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure--function relationships of rat hepatic tryptophan 2,3-dioxygenase: identification of the putative heme-ligating histidine residues.
    Dick R; Murray BP; Reid MJ; Correia MA
    Arch Biochem Biophys; 2001 Aug; 392(1):71-8. PubMed ID: 11469796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of delta-aminolevulinic acid synthase and cytochrome PB1 P450 messenger RNA levels by dihydropyridines, dihydroquinolines, sydnones, and N-ethylprotoporphyrin IX.
    Mackie JE; Back DW; Hamilton JW; Marks GS
    Biochem Pharmacol; 1991 Jul; 42(3):475-83. PubMed ID: 1859461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man.
    Gardner LC; Smith SJ; Cox TM
    J Biol Chem; 1991 Nov; 266(32):22010-8. PubMed ID: 1939222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.